If you want to monitor your vital signs like an Olympic athlete, you should welcome a pact between glucose-monitor vendor ...

The collaboration between NABH and RSSDI seeks to elevate diabetes care quality by establishing robust accreditation ...

A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.

A new study led by researchers at The University of Texas at Austin and Harvard Medical School reveals surprising findings ...

Study estimates 136.8 million U.S. adults are eligible for semaglutide, a popular therapy for diabetes, weight loss, and cardiovascular disease.

The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

From no sidewalks to proliferation of smartphones and screens, modern life is rife with obstacles to active lifestyles, which ...

Data reveal a strong association between non–high-density lipoprotein (non-HDL) cholesterol to HDL cholesterol ratio and ...

Ultimately, she wants people to know that as people with diabetes, “we can live really robust lives.” One peek at her social ...

In the United States and worldwide, alcohol consumption remains a leading cause of preventable death and disability.

The holidays are near, and so is the season of eating decadent meals – and sometimes, overeating. Overindulging on food is ...

People diagnosed with type 2 diabetes at a younger age are at a higher risk for developing dementia than those diagnosed ...